In early July, the German Institute for Quality and Efficiency in Health Care (IQWiG) conducted two early benefit assessments to investigate whether certain drug combinations with pembrolizumab have advantages in comparison with the respective appropriate comparator therapy for patients with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC). Due to a contradictory presentation of […]
Home »
Immunotherapy may become new first line treatment in some metastatic colorectal cancers
Immunotherapy with nivolumab and low-dose ipilimumab could become a new first line treatment in patients with some metastatic colorectal cancers following late-breaking results from the CheckMate-142 trial reported at the ESMO 2018 Congress in Munich. The drug combination shrank tumours and had beneficial effects on survival in patients with microsatellite instabiliy (MSI)-high metastatic colorectal cancer. […]
Mira Sorvino Discusses Metastatic Breast Cancer & the Connection With #MeToo
Pin Mira Sorvino frequently lends her voice to causes that help other people, whether it’s serving as an U.N. goodwill ambassador to combat human trafficking or speaking out on behalf of people who have experienced sexual violence via the #MeToo movement. In addition, the Academy Award-winning actor has also teamed up with #MoreForMBC: A campaign […]
Engineered cancer cells can fight primary and metastatic cancer
What if cancer cells could be re-engineered to turn against their own kind? A new study led by researchers at Brigham and Women’s Hospital leverages the power of gene editing to take a critical step toward using cancer cells to kill cancer. The team reports promising results in preclinical models across multiple types of cancer […]